Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E (including mixed tocopherols) has been investigated for its potential role in the prevention and treatment of cataracts, primarily due to its antioxidant properties. The lens of the eye is particularly susceptible to oxidative stress, and oxidative damage is believed to be a contributing factor in the development of cataracts. Vitamin E, as a lipid-soluble antioxidant, could theoretically help protect lens proteins and lipids from oxidation.

Epidemiological studies have shown mixed results regarding the association between Vitamin E intake and cataract risk. Some observational studies suggest that higher dietary or supplemental intake of Vitamin E may be associated with a reduced risk of cataract formation. However, randomized controlled trials (RCTs), such as the Age-Related Eye Disease Study (AREDS) and others, have not demonstrated a significant protective effect of Vitamin E supplementation against cataract progression or incidence.

Current scientific consensus is that while there is a plausible biological mechanism and some observational support, the overall evidence from interventional studies is weak and inconsistent. Major eye health organizations do not recommend Vitamin E supplementation specifically for cataract prevention or treatment. Therefore, the use of Vitamin E for cataracts is based on limited scientific evidence, and it is not a standard or proven therapy for this condition.

More about Viramin E (mixed tocopherols)
More about Cataracts

Other ingredients used for Cataracts

Other health conditions supported by Viramin E (mixed tocopherols)

Products containing Viramin E (mixed tocopherols)